These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33162381)

  • 1. The impact of COVID-19 on pharmacy transitions of care services.
    Herzik KA; Bethishou L
    Res Social Adm Pharm; 2021 Jan; 17(1):1908-1912. PubMed ID: 33162381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic.
    Lynch M; O'Leary AC
    Res Social Adm Pharm; 2021 Jan; 17(1):1913-1919. PubMed ID: 32893134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist Role in Transitions of Care.
    Consult Pharm; 2017 Oct; 32(10):645-649. PubMed ID: 28992825
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist linkage in care transitions: From academic medical center to community.
    Bloodworth LS; Malinowski SS; Lirette ST; Ross LA
    J Am Pharm Assoc (2003); 2019; 59(6):896-904. PubMed ID: 31590926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration Strategies of Pharmacists in Primary Care-Based Accountable Care Organizations: A Report from the Accountable Care Organization Research Network, Services, and Education.
    Joseph T; Hale GM; Eltaki SM; Prados Y; Jones R; Seamon MJ; Moreau C; Gernant SA
    J Manag Care Spec Pharm; 2017 May; 23(5):541-548. PubMed ID: 28448780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Community Pharmacists in Transition of Care (TOC) Services: Current Trends and Pharmacist Perceptions.
    Zeleznikar EA; Kroehl ME; Perica KM; Thompson AM; Trinkley KE
    J Pharm Pract; 2019 Feb; 32(1):28-35. PubMed ID: 29061080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving care transitions: current practice and future opportunities for pharmacists.
    ; Hume AL; Kirwin J; Bieber HL; Couchenour RL; Hall DL; Kennedy AK; LaPointe NM; Burkhardt CD; Schilli K; Seaton T; Trujillo J; Wiggins B
    Pharmacotherapy; 2012 Nov; 32(11):e326-37. PubMed ID: 23108810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuity of care: a basis for professional unity in pharmacy.
    Ray MD
    Am J Health Syst Pharm; 2005 Aug; 62(16):1654. PubMed ID: 16085927
    [No Abstract]   [Full Text] [Related]  

  • 11. Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists.
    Elnaem MH; Cheema E
    Res Social Adm Pharm; 2021 Jan; 17(1):1938-1941. PubMed ID: 32507575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic.
    Merks P; Jakubowska M; Drelich E; Świeczkowski D; Bogusz J; Bilmin K; Sola KF; May A; Majchrowska A; Koziol M; Pawlikowski J; Jaguszewski M; Vaillancourt R
    Res Social Adm Pharm; 2021 Jan; 17(1):1807-1812. PubMed ID: 32546449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving care transitions through medication therapy management: A community partnership to reduce readmissions in multiple health-systems.
    Heaton PC; Frede S; Kordahi A; Lowery L; Moorhead B; Kirby J; Kunze N; Luder H
    J Am Pharm Assoc (2003); 2019; 59(3):319-328. PubMed ID: 30819640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with technology-supported transitions of care to improve medication use.
    Frail CK; Garza OW; Haas AL
    J Am Pharm Assoc (2003); 2016; 56(5):568-72. PubMed ID: 27521168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in pharmacy-based transition-of-care activities in the United States: a national survey.
    Kern KA; Kalus JS; Bush C; Chen D; Szandzik EG; Haque NZ
    Am J Health Syst Pharm; 2014 Apr; 71(8):648-56. PubMed ID: 24688039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and operational redesigning of patient-centered ambulatory care pharmacy services and its effectiveness during the COVID-19 pandemic.
    Thorakkattil SA; Nemr HS; Al-Ghamdi FH; Jabbour RJ; Al-Qaaneh AM
    Res Social Adm Pharm; 2021 Jan; 17(1):1838-1844. PubMed ID: 33317762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
    Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
    J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-maker and staff perceptions of the pharmacist's role in transitions of care programs.
    Foster AR; Gatewood SS; Kaefer TN; Goode JKR
    J Am Pharm Assoc (2003); 2019; 59(4S):S101-S105. PubMed ID: 31080151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding opportunities through patient care: Pharmacists provide care...let me tell you about it.
    Brown L
    J Am Pharm Assoc (2003); 2015; 55(4):348-53. PubMed ID: 26161478
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementation of transitions-of-care services through acute care and outpatient pharmacy collaboration.
    Gilmore V; Efird L; Fu D; LeBlanc Y; Nesbit T; Swarthout M
    Am J Health Syst Pharm; 2015 May; 72(9):737-44. PubMed ID: 25873621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.